IperionX (NASDAQ:IPX) Reaches New 52-Week Low – What’s Next?

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $20.09 and last traded at $20.25, with a volume of 479992 shares. The stock had previously closed at $22.19.

Analysts Set New Price Targets

Several research firms have recently issued reports on IPX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a research report on Friday, July 17th. Alliance Global Partners reissued a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th. BTIG Research boosted their target price on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, June 5th. Finally, Roth Capital restated a “buy” rating on shares of IperionX in a research note on Monday, June 8th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, IperionX currently has an average rating of “Moderate Buy” and an average target price of $60.33.

Get Our Latest Stock Analysis on IPX

IperionX Trading Down 3.7%

The stock’s 50-day moving average is $29.85 and its 200 day moving average is $35.79. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00.

Insider Buying and Selling at IperionX

In other news, Chairman Todd Hannigan acquired 300,000 shares of the company’s stock in a transaction on Monday, July 13th. The shares were bought at an average price of $3.59 per share, with a total value of $1,077,000.00. Following the completion of the acquisition, the chairman owned 26,633,334 shares in the company, valued at $95,613,669.06. This trade represents a 1.14% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Anastasios Arima bought 138,720 shares of the business’s stock in a transaction dated Friday, July 10th. The shares were purchased at an average price of $3.58 per share, for a total transaction of $496,617.60. Following the transaction, the chief executive officer directly owned 12,455,502 shares of the company’s stock, valued at approximately $44,590,697.16. This represents a 1.13% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired 663,720 shares of company stock valued at $2,379,118 in the last 90 days.

Institutional Trading of IperionX

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC grew its stake in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock worth $50,000 after buying an additional 483 shares during the last quarter. JPMorgan Chase & Co. purchased a new stake in IperionX in the second quarter valued at approximately $66,000. State of Tennessee Department of Treasury purchased a new stake in IperionX in the fourth quarter valued at approximately $119,000. DV Equities LLC acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $178,000. Finally, Man Group plc acquired a new stake in shares of IperionX in the fourth quarter valued at approximately $257,000. 2.76% of the stock is owned by institutional investors and hedge funds.

IperionX Company Profile

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

See Also

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.